Scynexis (SCYX) Cash from Investing Activities (2013 - 2026)

Scynexis (SCYX) posted Cash from Investing Activities of -$525000.0 for Q1 2026, up 95.56% on a QoQ basis from -$11.8 million in Q4 2025, and down 104.22% year-over-year from $12.4 million in Q1 2025.

Scynexis (SCYX) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Scynexis' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$525000.0 for Q1 2026.

  • Quarterly Cash from Investing Activities fell 104.22% year-over-year to -$525000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (down 13.66% YoY) and the FY2025 annual result came in at $24.3 million, up 295.22% from the prior year.
  • Cash from Investing Activities was -$525000.0 for Q1 2026 at Scynexis, up from -$11.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $12.4 million in Q1 2025 and bottomed at -$27.4 million in Q3 2022.
  • A 5-year average of -$2.3 million and a median of -$267000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 8000.59% — and 2025, when it surged 721.65%.
  • Scynexis' Cash from Investing Activities stood at -$27.4 million in 2022, then jumped by 92.14% to -$2.2 million in 2023, then fell by 21.61% to -$2.6 million in 2024, then sank by 351.82% to -$11.8 million in 2025, then soared by 95.56% to -$525000.0 in 2026.
  • Business Quant data shows SCYX's Cash from Investing Activities at -$525000.0 in Q1 2026, -$11.8 million in Q4 2025, and $12.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.82 Bn 87.96 Bn - -
2 Teva Pharmaceutical Industries 36.03 Bn 32.29 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.48 Bn 30.54 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.50 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.02 Bn 20.86 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.43 Bn 18.63 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.77 Bn 16.46 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.73 Bn 12.30 Bn 785.00 Mn -60.00 Mn
10 Scynexis 23.19 Mn -13.57 Mn - -525,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -525,000.00
Mar 31, 2026 -525,000.00
Dec 31, 2025 -11.82 Mn
Dec 31, 2025 -11.82 Mn
Sep 30, 2025 12.42 Mn
Sep 30, 2025 12.42 Mn
Jun 30, 2025 11.27 Mn
Jun 30, 2025 11.27 Mn
Mar 31, 2025 12.44 Mn
Mar 31, 2025 12.44 Mn
Dec 31, 2024 -2.62 Mn
Dec 31, 2024 -2.62 Mn
Sep 30, 2024 1.94 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.37 Mn
Jun 30, 2024 1.37 Mn
Mar 31, 2024 5.45 Mn
Mar 31, 2024 5.45 Mn
Dec 31, 2023 -2.15 Mn
Dec 31, 2023 -2.15 Mn